Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)
Clinical trial NCT04110275 · UNKNOWN
Trial details
- NCT number
- NCT04110275
- Sponsor
- Angde Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-05-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.